Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Research
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
Paris, March 20, 2025. Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under w…
Patient Education Webcasts
The Future of Myeloma Treatment: What’s Next?
Research
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
SAN DIEGO, Feb. 05, 2025 - Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. today announced positive topline results from KOMET-001, the Phase 2 registra…
Research
BioInvent announces promising initial efficacy data from triple combination arm of BI-1206, rituximab and Calquence for the treatment of non-Hodgkin's lymphoma
Lund, Sweden – January 8, 2025 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and dev…
Professional Education Webcasts
Blood Cancer 101: The Basics on Disease, Treatment, and the Role of the HCP
This activity is intended for oncology social workers, psychologists, nurses, and other healthcare professionals involved in the care of patients with…
Patient Education Webcasts
Webcasts y Videos en Español
Estos programas están disponibles en español. Haga clic en los enlaces a continuación para acceder a transmisiones web, repeticiones de audio, transcr…
News
25 Patient and Provider Groups Applaud Supreme Court Ruling, Though Express Concern About Other Plaintiffs Keeping FDA Authority Challenge Alive
WASHINGTON, D.C., June 13, 2024 – Our 25 organizations, representing patients with serious health conditions and disabilities and their providers, app…
Patient Education Webcasts
Breakthroughs and Progress: Acute Myeloid Leukemia (AML)
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
